Kuczmarski, Thomas
Stommel, Elijah W.
Riley, Kristen
Tandan, Rup
Chaudhry, Vinay
Clawson, Lora
Caller, Tracie A.
Henegan, Patricia L.
Facciponte, Dominic N.
Bradley, Walter G.
Andrew, Angeline S. http://orcid.org/0000-0002-3731-5300
Funding for this research was provided by:
Amyotrophic Lateral Sclerosis Association (SC5181 and 15-IIP-213)
Centers for Disease Control (CDC) / Agency for Toxic Substances and Disease Registry (200-2014-59046)
National Center for Advancing Translational Sciences (UL1TR001086)
Agency for Toxic Substances and Disease Registry (R01TS1000245)
Article History
Received: 14 March 2017
Revised: 26 June 2017
Accepted: 29 June 2017
First Online: 15 July 2017
Compliance with ethical standards
:
: All study procedures were approved by the Committee for Protection of Human Subjects at Dartmouth College, the Committee on Human Research in the Medical Sciences at the University of Vermont, and the Office of Human Subjects Research at Johns Hopkins Medicine. All data was collected from patients who consented to participation in the study.
: The authors declare that they have no conflict of interest.